Gala vs Willow: Which GLP-1 Provider Is Better?
By Iacob Pastina, Independent Researcher
Willow beats Gala overall, scoring 8.2/10 vs 7/10. Gala is more affordable at $149/mo vs $299/mo. Choose Gala for users who want low-cost compounded tirzepatide and a built-i. Choose Willow for users who want comprehensive clinical support with flexibili.
A side-by-side comparison of Gala and Willow covering pricing, scores, medication types, insurance, and more to help you decide.
Gala
#40 of 42Telehealth platform offering compounded semaglutide and tirzepatide at competitive pricing, plus a paid path to brand semaglutide. Differentiator: a dedicated iOS GLP-1 tracker app for users who want to log dosing, weight, and side effects in one place.
Visit GalaWillow
#8 of 42Personalized GLP-1 weight loss with ongoing clinical support. Compounded semaglutide and tirzepatide only — Willow explicitly does not prescribe brand-name Wegovy or Zepbound. Added oral compounded semaglutide tablets as a non-injectable option.
Visit Willow| Feature | Gala | Willow |
|---|---|---|
| Our Score | 7/10 | 8.2/10 |
| Starting Price | $149/mo | $299/mo |
| Medication Type | Both | Compounded |
| Insurance Accepted | No | No |
| Best For | Users who want low-cost compounded tirzepatide and a built-in iOS tracker app for daily progress logging | Users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes |
| Ranking | #40 | #8 |
Pros & Cons Compared
Gala
Pros
- +Compounded tirzepatide as low as $149/mo on the longest commitment plan — among the cheapest tirz options on the market
- +$199/mo entry pricing on a 3-month plan for compounded semaglutide — competitive in the mid-tier
- +Dedicated 'Gala GLP-1 Tracker' iOS app for dosing, weight, and side-effect logging — uncommon among compounded-only platforms
- +Both semaglutide and tirzepatide available, plus a brand-name semaglutide path for users who specifically want FDA-approved
Cons
- −Brand-name semaglutide pricing ($1,299/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo
- −Mixed Trustpilot reviews mention dosing inconsistencies and slow customer service responsiveness
- −Newer brand (Delaware-registered, limited public company history) — less track record than established platforms like Henry Meds or Sprout
- −No published lab panels or specialty clinical oversight — state-licensed prescriber review is the standard, not differentiated
Willow
Pros
- +Includes monthly provider check-ins and dose adjustments at no extra cost
- +Offers both injectable AND oral compounded semaglutide — one of few platforms with a daily oral tablet option
- +$299/mo all-in for compounded semaglutide with monthly provider support
- +90%+ patient retention rate after 3 months per their published outcomes data
Cons
- −Compounded-only — no brand-name Wegovy or Zepbound through the platform
- −Tirzepatide pricing reaches $499-$524 at higher doses — starting dose is $399/mo
- −Cash-pay only — no insurance billing, though they provide superbills for FSA/HSA
- −Founded in 2024 — less track record than Ro or Hims, though growth has been fast
Our Verdict
Willow edges out Gala with a score of 8.2/10 vs 7/10. If budget is your priority, Gala starts at $149/mo compared to Willow's $299/mo. Gala offers both brand-name and compounded medications, giving you more flexibility. Choose Gala if you want: users who want low-cost compounded tirzepatide and a built-in ios tracker app for daily progress logging. Choose Willow if you want: users who want comprehensive clinical support with flexibility between injectable and oral compounded semaglutide routes.